Site Map
Posts
- Category: Wp Feeds (continued)
- New Tenofovir Stakes Claim in HBV (CME/CE)
- New Test May Identify Best Patients for Immunotherapy
- Newer HCV Agents Mostly Cost-Effective (CME/CE)
- Newman's Notes: Inside the Ondansetron Black Box (CME/CE)
- Next Session of Congress: It's All About the Money
- NIH Not Tracking Gender-Specific Results in Trials it Sponsors
- NIH Program Director Talks Team Work to Tackle ME-CFS
- Nivolumab Slows Advanced Gastric Cancer
- No Added Benefit for Chemo Beads in Liver Cancer
- No Approval for Rifaximin in IBS
- No Benefit for Steroids in Allograft Renal Transplant (CME/CE)
- No Benefit From Ezetimibe in NASH (CME/CE)
- No Benefit Seen for Probiotics in Ulcerative Colitis
- No Change for Doc Pay: MedPac
- No Clear Winner in C. Difficile Battle (CME/CE)
- No Elevated Heart Risk in IBD
- No IBD Risk Seen with Acne Drug (CME/CE)
- No Increase in Intussusception With Rotavirus Vaccine (CME/CE, with video)
- No Increased IBD Risk With Cosentyx (CME/CE)
- No Mortality Benefit From Pentoxifylline in Alcoholic Hepatitis (CME/CE)
- No Single Reason for Readmission After GI Surgery (CME/CE)
- No Spike in Cardiac Arrest Among Athletes During the Pandemic, Study Says
- No Surgery for Appendicitis Passes Test in Kids
- No Survival Advantage in Pancreatic Ca With Metformin (CME/CE)
- No Survival Gain with Aspirin in Colon Cancer
- No Ties Between Early Antibiotics and T1D or Celiac Disease (CME/CE)
- No Tx Frontrunners in Colorectal Cancer Trials
- No Wheat or Barley on the Label? Be Careful, There Could Still Be Gluten
- Nodes Don't Add Up for Better Colon Cancer Staging (CME/CE)
- Non-Alcoholic Fatty Liver: Risk Factor for Hypertension? (CME/CE)
- Non-V600 BRAF Mutation Tied to Better CRC Prognosis (CME/CE)
- Nonsurgical Treatment of Rectal Cancer Questioned (CME/CE)
- Nontoxic Battery Promising for Ingestible Devices
- Norovirus Main Gastroenteritis Culprit in Kids (CME/CE)
- Norovirus Tied to Nursing Home Deaths (CME/CE)
- Norovirus Tied to Nursing Home Deaths (CME/CE)
- Norovirus Vax Cuts Severity of GI Symptoms
- Not Enough Funding in 'Cures' Bill, FDA Chief Warns
- Not Much to Show for Nation's High Cost of Care
- Novavax Says Its COVID Shot Is on Track for Full FDA Approval After Delay
- Novel Agent Shows Antitumor Activity in TRK-Fusion Cancers
- Novel Biliary Stent Proves Long-Term Mettle
- Novel C. Diff Drug Questioned in FDA Staff Review
- Novel Drug Combo Succeeds Against Multiple HCV Genotypes (CME/CE)
- Novel Drug Eases Chronic Constipation (CME/CE)
- Novel Drug Offers Hope in Rare Liver Disease (CME/CE)
- Novel Drug Shows Promise in Gastric Cancer
- Novel Drug Works Against Hepatitis C
- Novel HCV Drug Can Double Response Rate (CME/CE)
- Novel HCV Drug Can Double Response Rate (CME/CE)
